226 related articles for article (PubMed ID: 32618442)
1. Blau Syndrome: NOD2-related systemic autoinflammatory granulomatosis.
Takada S; Saito MK; Kambe N
G Ital Dermatol Venereol; 2020 Oct; 155(5):537-541. PubMed ID: 32618442
[TBL] [Abstract][Full Text] [Related]
2. Potential Benefits of TNF Targeting Therapy in Blau Syndrome, a NOD2-Associated Systemic Autoinflammatory Granulomatosis.
Matsuda T; Kambe N; Takimoto-Ito R; Ueki Y; Nakamizo S; Saito MK; Takei S; Kanazawa N
Front Immunol; 2022; 13():895765. PubMed ID: 35711422
[TBL] [Abstract][Full Text] [Related]
3. A novel nucleotide oligomerisation domain 2 mutation in a family with Blau syndrome: Phenotype and function.
Ong LT; Nachbur U; Rowczenio D; Ziegler JB; Fischer E; Lin MW
Innate Immun; 2017 Oct; 23(7):578-583. PubMed ID: 28836875
[TBL] [Abstract][Full Text] [Related]
4. A novel mutation in early-onset sarcoidosis/Blau syndrome: an association with Propionibacterium acnes.
Okazaki F; Wakiguchi H; Korenaga Y; Nakamura T; Yasudo H; Uchi S; Yanai R; Asano N; Hoshii Y; Tanabe T; Izawa K; Honda Y; Nishikomori R; Uchida K; Eishi Y; Ohga S; Hasegawa S
Pediatr Rheumatol Online J; 2021 Feb; 19(1):18. PubMed ID: 33602264
[TBL] [Abstract][Full Text] [Related]
5. A case of infantile Takayasu arteritis with a p.D382E NOD2 mutation: an unusual phenotype of Blau syndrome/early-onset sarcoidosis?
Inoue Y; Kawaguchi Y; Shimojo N; Yamaguchi K; Morita Y; Nakano T; Arima T; Tomiita M; Kohno Y
Mod Rheumatol; 2013 Jul; 23(4):837-9. PubMed ID: 22821420
[TBL] [Abstract][Full Text] [Related]
6. Blau Syndrome With Delayed Cutaneous Manifestations: A Case Report.
Panah E; Garfield E; Zahirsha Z; Muhlbauer A; Lake E; Speiser J
Am J Dermatopathol; 2024 Jun; 46(6):381-382. PubMed ID: 38648024
[TBL] [Abstract][Full Text] [Related]
7. Role of the NOD2 genotype in the clinical phenotype of Blau syndrome and early-onset sarcoidosis.
Okafuji I; Nishikomori R; Kanazawa N; Kambe N; Fujisawa A; Yamazaki S; Saito M; Yoshioka T; Kawai T; Sakai H; Tanizaki H; Heike T; Miyachi Y; Nakahata T
Arthritis Rheum; 2009 Jan; 60(1):242-50. PubMed ID: 19116920
[TBL] [Abstract][Full Text] [Related]
8. A Novel Pathogenic
Rodrigues FG; Petrushkin H; Webster AR; Bickerstaff M; Moraitis E; Rowczenio D; Aróstegui JI; Westcott M
Ophthalmic Genet; 2021 Dec; 42(6):753-764. PubMed ID: 34251956
[TBL] [Abstract][Full Text] [Related]
9. Pluripotent stem cell models of Blau syndrome reveal an IFN-γ-dependent inflammatory response in macrophages.
Takada S; Kambe N; Kawasaki Y; Niwa A; Honda-Ozaki F; Kobayashi K; Osawa M; Nagahashi A; Semi K; Hotta A; Asaka I; Yamada Y; Nishikomori R; Heike T; Matsue H; Nakahata T; Saito MK
J Allergy Clin Immunol; 2018 Jan; 141(1):339-349.e11. PubMed ID: 28587749
[TBL] [Abstract][Full Text] [Related]
10. Blau syndrome with pulmonary nodule in a child.
Su J; Liu D
Australas J Dermatol; 2021 May; 62(2):217-220. PubMed ID: 33742458
[TBL] [Abstract][Full Text] [Related]
11. Blau syndrome-associated Nod2 mutation alters expression of full-length NOD2 and limits responses to muramyl dipeptide in knock-in mice.
Dugan J; Griffiths E; Snow P; Rosenzweig H; Lee E; Brown B; Carr DW; Rose C; Rosenbaum J; Davey MP
J Immunol; 2015 Jan; 194(1):349-57. PubMed ID: 25429073
[TBL] [Abstract][Full Text] [Related]
12. Blau syndrome NOD2 mutations result in loss of NOD2 cross-regulatory function.
Mao L; Dhar A; Meng G; Fuss I; Montgomery-Recht K; Yang Z; Xu Q; Kitani A; Strober W
Front Immunol; 2022; 13():988862. PubMed ID: 36189261
[TBL] [Abstract][Full Text] [Related]
13. Exacerbation of symptoms in Blau syndrome/early-onset sarcoidosis following delivery.
Mizawa M; Makino T; Nakamura T; Yamaguchi S; Taki H; Shimizu T
Eur J Dermatol; 2015; 25(6):620-2. PubMed ID: 26712281
[No Abstract] [Full Text] [Related]
14. [The present and the prospect of study on Blau syndrome/early-onset sarcoidosis].
Nakano M; Kambe N
Nihon Rinsho; 2013 Apr; 71(4):737-41. PubMed ID: 23678609
[TBL] [Abstract][Full Text] [Related]
15. Blau syndrome with a rare mutation in exon 9 of
Velickovic J; Silan F; Bir FD; Silan C; Albuz B; Ozdemir O
Autoimmunity; 2019; 52(7-8):256-263. PubMed ID: 31556326
[TBL] [Abstract][Full Text] [Related]
16. Genetic and Clinical Features of Blau Syndrome among Chinese Patients with Uveitis.
Zhong Z; Ding J; Su G; Liao W; Gao Y; Zhu Y; Deng Y; Li F; Du L; Gao Y; Yang P
Ophthalmology; 2022 Jul; 129(7):821-828. PubMed ID: 35314268
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and treatment of 50 cases of Blau syndrome in Japan confirmed by genetic analysis of the
Matsuda T; Kambe N; Ueki Y; Kanazawa N; Izawa K; Honda Y; Kawakami A; Takei S; Tonomura K; Inoue M; Kobayashi H; Okafuji I; Sakurai Y; Kato N; Maruyama Y; Inoue Y; Otsubo Y; Makino T; Okada S; Kobayashi I; Yashiro M; Ito S; Fujii H; Kondo Y; Okamoto N; Ito S; Iwata N; Kaneko U; Doi M; Hosokawa J; Ohara O; Saito MK; Nishikomori R; ;
Ann Rheum Dis; 2020 Nov; 79(11):1492-1499. PubMed ID: 32647028
[TBL] [Abstract][Full Text] [Related]
18. Blau syndrome with NOD2 mutation in a 54-year-old man: A case report.
Wang Z; Yang M; Zhang Q; Zhang S; Sui H; Liu J; Yang Q
Int J Rheum Dis; 2023 Oct; 26(10):2080-2084. PubMed ID: 37246600
[TBL] [Abstract][Full Text] [Related]
19. Nucleotide-binding oligomerization domain containing 2: structure, function, and diseases.
Yao Q
Semin Arthritis Rheum; 2013 Aug; 43(1):125-30. PubMed ID: 23352252
[TBL] [Abstract][Full Text] [Related]
20. A Novel Mutation in Helical Domain 2 of NOD2 in Sporadic Blau Syndrome.
Jain L; Gupta N; Reddy MM; Mittal R; Barik MR; Panigrahi B; Monie T; Basu S
Ocul Immunol Inflamm; 2018; 26(2):292-294. PubMed ID: 27625029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
